Adaptation of the Rey Auditory Verbal Learning Test and Logical Memory Subtest from the Wechsler Memory Scales – 3rd Edition to assess accelerated long‐term forgetting in adults with epilepsy
Epileptic Disorders · 2025
DOI: 10.1002/epd2.70084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epileptic Disorders, 2025. Verfasst von Amélie Landry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Département de Psychologie, Université du Québec à Montréal (UQAM), Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Verbal Learning, Epilepsy, Memory Disorders, Neuropsychological Tests. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Savoy Foundation, Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Objective
The present study provides normative data for adapted versions of the Rey Auditory Verbal Learning Test (RAVLT) and the Logical Memory subtest from the Wechsler Memory Scales – 3rd edition (WMS‐III‐LM), involving both recall and recognition procedures after a 2‐week delay to assess accelerated long‐term forgetting (ALF). The study also aims to achieve a clinical validation of these tests in a group of people with epilepsy (PWE).
Methods
A total of 124 (18–55 years old) healthy participants and 30 PWE undergoing presurgical monitoring for drug‐resistant seizures completed these tasks. Associations between memory performance and sociodemographic, neuropsychological function, and testing factors were examined among healthy participants. Memory performance was compared between healthy and PWE groups, with special attention to forgetting rates over 2 weeks as a measure of long‐term consolidation.
Results
Contrarily to raw recall and recognition performance, forgetting rates over 2 weeks were not significantly modulated by age or sex. As expected, higher forgetting rates and a greater prevalence of ALF were found among PWE compared with healthy participants on both tests. Significance This study offers useful normative data to assess ALF in PWE and provides clinical evidence that our adapted tests can identify long‐term consolidation impairments in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Département de Psychologie, Université du Québec à Montréal (UQAM), Montréal, Québec, Canada.
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
- Département de Neurosciences, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada.
- Département de Psychologie, Université de Montréal, Montréal, Québec, Canada.
- Service de Psychologie, Centre Hospitalier de L'université de Montréal (CHUM), Montréal, Québec, Canada.
ORCID-Profile: Amélie Landry
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Savoy Foundation
- Fonds de Recherche du Québec - Santé
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Landry, A., Rouleau, I., Colucci, E., Nguyen, D. K., & Boucher, O. (2025). Adaptation of the Rey Auditory Verbal Learning Test and Logical Memory Subtest from the Wechsler Memory Scales – 3rd Edition to assess accelerated long‐term forgetting in adults with epilepsy. Epileptic Disorders. https://doi.org/10.1002/epd2.70084
Vancouver
Landry A, Rouleau I, Colucci E, Nguyen DK, Boucher O. Adaptation of the Rey Auditory Verbal Learning Test and Logical Memory Subtest from the Wechsler Memory Scales – 3rd Edition to assess accelerated long‐term forgetting in adults with epilepsy. Epileptic Disorders. 2025. doi:10.1002/epd2.70084
BibTeX
@article{Landry2025,
author = {Landry, Amélie and Rouleau, Isabelle and Colucci, Emma and Nguyen, Dang Khoa and Boucher, Olivier},
title = {Adaptation of the Rey Auditory Verbal Learning Test and Logical Memory Subtest from the Wechsler Memory Scales – 3rd Edition to assess accelerated long‐term forgetting in adults with epilepsy},
journal = {Epileptic Disorders},
year = {2025},
doi = {10.1002/epd2.70084}
}
EUVIMED